Department of Medicine

January 31, 2019

Study explores genetic risk for suicide attempt

Using data from the UK Biobank and Vanderbilt’s BioVU, a new study in the journal Molecular Psychiatry finds that approximately 4 percent of suicide attempt risk is captured by genotype data.

January 31, 2019

Research bolsters thyroid function, atrial fibrillation link

A study by researchers at Vanderbilt University Medical Center has strengthened the link between thyroid function and atrial fibrillation (AF), an irregular heart rhythm that increases the risk of stroke and other heart-related complications.

January 31, 2019

Cell death pathway implicated in bone marrow failure

Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.

John Koethe, MD, MSCI, left, Kevin Niswender, MD, PhD, LaToya Hannah, MSN, APRN, Matt Luther, MD, associate professor of Medicine, and colleagues have formed a new Human Metabolic Physiology Core at VUMC to support studies requiring human adipose tissue.
January 24, 2019

New core to support investigations into metabolic disorders

For several years Vanderbilt University Medical Center researchers have been studying adipose tissue to help unlock the mysteries behind metabolic disorders related to obesity, cardiovascular disease, diabetes and other health conditions, and now they have a new resource to support their investigations.

Jennifer Lutgens explores one of the new workstations at the Department of Medicine’s new space in the Oxford House.
January 24, 2019

Department of Medicine debuts new shared space in Oxford House

The fifth floor of the Oxford House has been remodeled into an innovative shared space for several groups in the Department of Medicine to use on an as-needed basis.

white pills spilling out of a prescription bottle
January 17, 2019

Pain relievers a risk for C. diff?

A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection.